A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
for Advanced Cancer
Sites in Denver +37 more locations
Sponsor: Artios Pharma Ltd
Sex: All·Age: 18+
Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020
Clinical Trials at Sarah Cannon Research Institute at HealthONE
As of August 2026, 27 paid clinical trials are recruiting at Sarah Cannon Research Institute at HealthONE in Denver, Colorado. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
27 clinical trials at Sarah Cannon Research Institute at HealthONE
·Clear filters·MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Denver +24 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for Esophageal Squamous Cell Carcinoma
Sites in Denver +14 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
for Small-cell Lung Cancer
Sites in Denver +12 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07174583·Phase 1, Phase 2·Recruiting·Listed Sep 2025
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
Drug: LY4052031
Sites in Denver +20 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting·Listed Jun 2024
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Denver, Aurora +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for HR+ Breast Cancer
Sites in Denver +17 more locations
Sponsor: NiKang Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07029399·Phase 1·Recruiting·Listed Jun 2025
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for Solid Tumor
Sites in Denver +10 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06619587·Phase 1·Recruiting·Listed Oct 2024
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for Small Cell Lung Cancer (SCLC)
Sites in Denver +14 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05652686·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Study of HLD-0915 in Patients With Metastatic Prostate Cancer
for Metastatic Prostate Cancer
Sites in Denver +10 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT06800313·Phase 1, Phase 2·Recruiting·Listed Jan 2025
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for Solid Tumors With HRAS Alterations
Sites in Denver +21 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06026410·Phase 1·Recruiting·Listed Sep 2023
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
for Advanced Solid Tumor
Drug: NXP900
Sites in Denver +12 more locations
Sponsor: Nuvectis Pharma, Inc.
Sex: All·Age: 18+
Code: NCT05873686·Phase 1·Recruiting·Listed May 2023
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
for Advanced Solid Tumor
Sites in Denver +2 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT04145622·Phase 1, Phase 2·Recruiting·Listed Oct 2019
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for Solid Tumor Malignancies
Sites in Denver +12 more locations
Sponsor: Tasca Therapeutics
Sex: All·Age: 18+
Code: NCT07030257·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
for Locally Advanced Solid Tumor
Sites in Denver +16 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 18+
Code: NCT06521554·Phase 1·Recruiting·Listed Jul 2024
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Denver +9 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06108050·Phase 1·Recruiting·Listed Oct 2023
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for Ovarian Cancer
Sites in Denver +13 more locations
Sponsor: OnCusp Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06234423·Phase 1·Recruiting·Listed Jan 2024
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
for Non-Small-Cell Lung
Sites in Denver +3 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07519655·Phase 1·Recruiting·Listed Apr 2026
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
for Ovarian Cancer
Drug: Bevacizumab
Sites in Denver +4 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07278336·Phase 1·Recruiting·Listed Dec 2025
First In Human Study of CX-2051 in Advanced Solid Tumors
for Solid Tumor, Adult
Sites in Denver +7 more locations
Sponsor: CytomX Therapeutics
Sex: All·Age: 18+
Code: NCT06265688·Phase 1·Recruiting·Listed Feb 2024
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Denver +7 more locations
Sponsor: Vaxiion Therapeutics
Sex: All·Age: 18+
Code: NCT05901285·Phase 1·Recruiting·Listed Jun 2023
SMP-3124LP in Adults With Advanced Solid Tumors
for Solid Tumor
Sites in Denver +8 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT06526819·Phase 1, Phase 2·Recruiting·Listed Jul 2024
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
for Locally Advanced/Metastatic Solid Tumors
Sites in Denver +4 more locations
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All·Age: 18+
Code: NCT06414460·Phase 1, Phase 2·Recruiting·Listed May 2024
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
for Malignant Mesothelioma
Sites in Denver +5 more locations
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All·Age: 18+
Code: NCT06566079·Phase 1·Recruiting·Listed Aug 2024
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
for Advanced Solid Tumors
Sites in Denver +5 more locations
Sponsor: Eikon Therapeutics
Sex: All·Age: 18 - 89
Code: NCT06907043·Phase 1, Phase 2·Recruiting·Listed Apr 2025
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Denver +4 more locations
Sponsor: ABL Bio, Inc.
Sex: All·Age: 18+
Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
for Cancer
Sites in Denver +5 more locations
Sponsor: Simcha IL-18, Inc.
Sex: All·Age: 18+
Code: NCT04787042·Phase 1, Phase 2·Recruiting·Listed Mar 2021
Common conditions studied in Denver
- Breast Cancer (18 active studies)
- Multiple Myeloma (17 active studies)
- Advanced Solid Tumor (15 active studies)
- Ovarian Cancer (11 active studies)
- Solid Tumor (11 active studies)
- Cystic Fibrosis (10 active studies)
Leading research sponsors in Denver
- University of Colorado, Denver
- Children's Oncology Group
- AstraZeneca
- National Cancer Institute (NCI)
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Denver?
There are approximately 524 recruiting clinical trials in Denver, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Denver pay participants?
Most recruiting trials in Denver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Denver?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Denver?
The most common conditions under active study in Denver include Breast Cancer (18), Multiple Myeloma (17), Advanced Solid Tumor (15), Ovarian Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Denver?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Denver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Denver?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Denver?
Recruiting research sites in Denver include Colorado Blood Cancer Institute, National Jewish Health, Sarah Cannon Research Institute at HealthONE, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Denver right now?
The largest active categories in Denver are Cancer & tumors (225), Cardiovascular (15), Diabetes & metabolic (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Colorado
Aurora, CO(1,048)Colorado Springs, CO(189)Lone Tree, CO(86)Englewood, CO(85)Fort Collins, CO(84)Lakewood, CO(78)Boulder, CO(64)Loveland, CO(58)Littleton, CO(53)Greeley, CO(49)Longmont, CO(44)Grand Junction, CO(42)Highlands Ranch, CO(36)Pueblo, CO(36)Golden, CO(33)Centennial, CO(31)Westminster, CO(31)Durango, CO(29)Thornton, CO(26)Wheat Ridge, CO(25)Lafayette, CO(21)Edwards, CO(18)Parker, CO(14)Greenwood Village, CO(12)Arvada, CO(11)Castle Rock, CO(9)Broomfield, CO(8)Brighton, CO(5)Dillon, CO(5)Evergreen, CO(4)Vail, CO(4)Basalt, CO(2)Glenwood Springs, CO(2)Greenwood, CO(2)Louisville, CO(2)Sheridan, CO(2)Steamboat Springs, CO(2)Air Force Academy, CO(1)Ault, CO(1)Carbondale, CO(1)Cheyenne Wells, CO(1)Craig, CO(1)Cripple Creek, CO(1)Ellicott, CO(1)Estes Park, CO(1)Falcon, CO(1)Firestone, CO(1)Fort Lupton, CO(1)Fountain, CO(1)Fruita, CO(1)Granada, CO(1)Gunnison, CO(1)La Junta, CO(1)Lamar, CO(1)Las Animas, CO(1)Manzanola, CO(1)Montrose, CO(1)Monument, CO(1)Platteville, CO(1)Sterling, CO(1)